Welcome to our dedicated page for Enovix SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enovix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enovix's regulatory disclosures and financial reporting.
Enovix Corporation’s Chief Operating Officer, Ajay Marathe, reported routine share withholding tied to equity compensation. On January 8, 2026, 1,493 and 4,544 shares of common stock were withheld at $7.91 per share to cover tax obligations arising from vesting restricted stock units (RSUs).
After these transactions, Marathe directly holds 927,421 shares of Enovix common stock. This figure includes 635,639 shares issuable upon future RSU vesting and 33,170 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. These movements reflect administrative tax withholding rather than discretionary open‑market trades.
Enovix Corporation reported that President and CEO Rajendra K. Talluri had shares of common stock withheld to cover taxes on vesting restricted stock units. On January 8, 2026, 4,301 and 13,725 shares of Enovix common stock were withheld at a price of $7.91 per share, with both transactions coded "F" and described as satisfying tax withholding obligations in connection with RSU vesting.
After these transactions, Talluri beneficially owned 2,243,254 shares of Enovix common stock directly, which includes 1,569,522 shares issuable upon settlement of RSUs and 95,551 vested performance RSUsMarch 2, 2026 and March 1, 2027, reflecting ongoing equity-based compensation rather than an open-market sale.
Enovix Corp’s Chief Operating Officer Ajay Marathe reported a tax-related share withholding tied to restricted stock units. On January 6, 2026, 42,557 shares of Enovix common stock were withheld at a price of $8.68 per share to satisfy tax obligations arising from the vesting of RSUs. After this withholding, Marathe beneficially owned 933,458 shares, including 638,458 shares issuable upon future RSU vesting and settlement and 33,170 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half on March 1, 2027, each representing the right to receive one share of Enovix common stock upon settlement.
Enovix Corp’s Chief Accounting Officer, Kristina Truong, reported a routine tax-related share withholding. On January 5, 2026, 697 shares of Enovix common stock were withheld at $8.73 per share to satisfy tax obligations tied to the vesting of restricted stock units (RSUs).
After this transaction, Truong beneficially owns 196,051 shares of Enovix common stock. This amount includes 147,679 shares issuable upon future RSU vesting and 4,978 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each performance RSU converts into one share upon settlement.
Enovix Corp's Chief Legal Officer, Arthi Chakravarthy, reported an automatic share withholding tied to equity compensation. On December 24, 2025, 2,217 shares of Enovix common stock were withheld at $8.27 per share to cover tax obligations arising from the vesting of restricted stock units (RSUs). After this transaction, Chakravarthy beneficially owned 418,228 shares, including 297,316 shares issuable upon future RSU vesting and 20,786 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half scheduled for release on March 1, 2027, each representing the right to receive one share of Enovix common stock.
Enovix Corp officer Kristina Truong, the Chief Accounting Officer, reported a routine equity transaction on December 13, 2025 related to restricted stock vesting.
The filing shows 1,013 shares of common stock were withheld at $ 8.64 per share to satisfy tax withholding obligations when her restricted stock units vested. After this, she beneficially owned 199,044 shares of Enovix common stock.
This total includes 153,082 shares that may be issued upon the vesting and settlement of RSUs and 4,978 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027. Each performance RSU represents a contingent right to receive one share of common stock upon settlement.
Enovix Corporation’s Chief Operating Officer, Ajay Marathe, reported a stock transaction dated December 14, 2025. The filing shows that 7,338 shares of common stock were withheld at $8.64 per share to cover tax withholding obligations triggered by the vesting of restricted stock units on that date.
After this transaction, Marathe is reported to beneficially own 980,535 shares of Enovix common stock. This total includes 727,116 shares issuable upon the vesting and settlement of RSUs and 33,170 vested performance RSUs, with half scheduled for release on March 2, 2026 and the other half on March 1, 2027, each PRSU representing the right to receive one share upon settlement.
Enovix Corp officer Kristina Truong reported a routine equity compensation event. On December 10, 2025, 252 shares of Enovix common stock were withheld at a price of $9.13 per share to satisfy tax withholding obligations tied to the vesting of restricted stock units.
After this transaction, she beneficially owns 200,057 shares of Enovix common stock. This includes 154,998 shares issuable upon the vesting and settlement of RSUs and 4,978 vested performance RSUs. Half of these performance RSUs are scheduled to be released on March 2, 2026, with the remaining half on March 1, 2027.
Enovix Corp (ENVX) reported an insider equity transaction by its Chief Accounting Officer, Kristina Truong. On November 21, 2025, she received 3,833 shares of common stock through a fully vested restricted stock unit (RSU) award, serving as her bonus for the quarter ended September 28, 2025. Each RSU converts into one share of Enovix common stock.
To cover tax withholding related to this RSU award, 2,026 shares of common stock were withheld and disposed of at a price of $7.47 per share. After these transactions, Truong beneficially owned 200,309 shares of Enovix common stock, including shares issuable from outstanding RSUs and vested performance RSUs scheduled for release in March 2026 and March 2027.
Enovix Corporation (ENVX) reported insider equity activity for its Chief Legal Officer, Arthi Chakravarthy. On November 21, 2025, she received 4,960 shares of common stock at a price of $0, issued upon the receipt of fully vested restricted stock units (RSUs) earned as bonus for the quarter ended September 28, 2025, with each RSU equal to one share.
To cover tax withholding on RSU vesting, 2,622 shares were withheld on November 21, 2025 at $7.47 per share and 2,217 shares were withheld on November 24, 2025 at $7.58 per share. Following these transactions, Chakravarthy beneficially owned 424,156 shares, including 303,276 shares issuable from RSUs and 20,786 vested performance RSUs scheduled for releases in March 2026 and March 2027.